In the UK, healthcare professionals in who prescribe or dispense ranitidine have been advised to identify current patients prescribed ranitidine tablets, effervescent tablets and oral solutions, review them to establish if ongoing treatment is still required, and consider switching to an alternative treatment, if needed.